Effectiveness of Artificial Intelligence–Based Platform in Administering Therapies for Children With Autism Spectrum Disorder: 12-Month Observational Study

Methodology

A 12-month observational study involving 43 children (aged 2–18 years) diagnosed with ASD.

Participants were divided into:

• Intervention group (n=35): Received standard therapy + CognitiveBotics platform.
• Control group (n=5): Received only standard therapy.

Standardized assessments used:

• Childhood Autism Rating Scale (CARS)
• Vineland Social Maturity Scale (VSMS)
• Developmental Screening Test (DST)
• Receptive Expressive Emergent Language Test (REEL)

Key Findings

The intervention group showed statistically significant improvements (p < .001) across all domains:

• CARS score reduced by 15.18%
• Social Age increased by 56.84%
• Developmental Age increased by 46.49%
• Receptive Language improved by 56.22%
• Expressive Language improved by 59.93%

The control group showed marginal or non-significant changes in these domains.